DIA Bioventure Day

Is the current Bioventure paradigm delivering return for patients and investors? This is the key question to be addressed by stakeholders from the funding, and from the innovating side.

戻る Agenda

Moderated Poster Walk & Networking Reception

Session Chair(s)

Joep Muijrers

Chief Financial Officer

PureTech Health, United States

David Haerry

Patient Advocate